• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 572

Lactase from Bifidobacterium bifidum produced in Bacillus licheniformis

Intended Use: For use in the dairy industry to catalyze the hydrolysis of lactose in the production of lactose reduced products at levels not to exceed the minimum amount necessary to achieve the intended technical effect.
Basis: Scientific procedures
Notifier: Novozymes North America, Inc.
Notifier Address: 77 Perry Chapel Church Road, P.O. Box 576, Franklinton, NC, 27525
Date of filing: Mar 23, 2015
GRAS Notice (releasable information): GRN 572 (in PDF) (1.4 MB)
Date of closure: Aug 28, 2015
FDA's Letter: FDA has no questions